BL-B16D1

· Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BL-B16D1, covering 2025-09-18 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors [Phase 1]

See pricing